Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Assistance Publique - Hôpitaux de Paris
National Cancer Institute (NCI)
Mayo Clinic
MP Biomedicals, LLC
University of Miami
National Institutes of Health Clinical Center (CC)
MP Biomedicals, LLC
National Institutes of Health Clinical Center (CC)
MP Biomedicals, LLC